Drug

Ranibizumab clinical trials

Also written RFB002.

studies test it: 350
open now: 6
in phase 3: 89
first study started: 2000

Keep track of what changes. Save the Ranibizumab studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Ranibizumab: 215
Lucentis: 185
Ranibizumab 0.5 mg: 13
Ranibizumab (Lucentis): 10
Ranibizumab 0.5mg: 9

Development codes

RFB002: 4
CMAB818: 1
QL1205: 1
rhuFab: 1
PF582: 1
DIN 02296810: 1
RO4893594: 1

Studies by the year they started

349 studies that test it; most in 2007 (38)

Studies that test Ranibizumab, by start year
Year	Studies
2000	1
2002	1
2003	3
2004	5
2005	8
2006	18
2007	38
2008	35
2009	24
2010	32
2011	28
2012	19
2013	27
2014	23
2015	24
2016	14
2017	11
2018	4
2019	5
2020	6
2021	10
2022	3
2023	3
2024	3
2025	2
2026	2

By phase

A phase 1/2 study counts in both.

Early Phase 1: 1
Phase 1: 81
Phase 2: 117
Phase 3: 89
Phase 4: 80
No phase: 33

What it is tested for

Each study’s main condition, where its own words name it.

Macular Degeneration: 100
Macular Edema: 85
Retinal Vein Occlusion: 21
Diabetic Retinopathy: 20
Vision Disorders: 12
Choroidal Neovascularization: 10
Retinopathy of Prematurity: 7
Polypoidal Choroidal Vasculopathy: 6
Glaucoma, Neovascular: 6
Telangiectasis: 6
Melanoma: 6
Glaucoma: 5

Who runs them

Industry 108 · Other 242

Novartis Pharmaceuticals (40) · Genentech, Inc. (17) · Novartis (11) · Hoffmann-La Roche (8) · National Eye Institute (NEI) (7) · California Retina Consultants (6) · Vitreous -Retina- Macula Consultants of New York (6) · University of Miami (5)

Often tested with

Tested in the same studies.

Bevacizumab (16) · Aflibercept (14) · Dexamethasone (9) · Verteporfin (7) · Dexamethasone Intravitreal Implant (4) · Photodynamic Therapy (4) · DRUG 601 (2) · LKA651 (2)

Related medicines

As reviewed, each with the page that says it.

One of Angiogenesis Inhibitors source

Studies

Open first, then newest update. How each study uses Ranibizumab is read from its arms, and is right about nine times in ten.

Testing it · 350

See all 350 studies that test Ranibizumab →

Given in every arm · 58 — Ranibizumab is usual care beside what is tested

Showing 20 of 58.

As the comparator · 59 — what is tested is compared with Ranibizumab

Showing 20 of 59.

Codes

What other systems call Ranibizumab · ClinicalTrials.gg INT006612

MeSH (NLM) D000069579RanibizumabConfirmed ClinicalTrials.gov, NLM, Wikidata
UNII (FDA) ZL1R02VT79RANIBIZUMABConfirmed FDA, NLM, Wikidata
RxNorm 595060Confirmed FDA, Wikidata
Wikidata Q414270ranibizumabConfirmed FDA, NLM, Wikidata
NCI Thesaurus C67562RanibizumabOne source FDA
DrugBank DB01270One source Wikidata

System	Code	Name there	Checked by
MeSH (NLM)	D000069579	Ranibizumab	Confirmed ClinicalTrials.gov, NLM, Wikidata
UNII (FDA)	ZL1R02VT79	RANIBIZUMAB	Confirmed FDA, NLM, Wikidata
RxNorm	595060	—	Confirmed FDA, Wikidata
Wikidata	Q414270	ranibizumab	Confirmed FDA, NLM, Wikidata
NCI Thesaurus	C67562	Ranibizumab	One source FDA
DrugBank	DB01270	—	One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.